The PRIME Study: A Randomized, Controlled, Prospective Study

Exclusion Criteria

• •Patients under the age of 22 or above the age of 75
• •Patients who are pregnant (must be ruled out in a women of child-bearing age with pregnancy test).
• •Patients with active infectious ocular or extraocular disease.
• •Patients actively treated with local or systemic immunosuppression including systemic corticosteriods
• •Paitents with know hypersensitivity to Dexamethasone
• •Patients with severe disease that warrants critical attentino, deemed unsafe for the study by the investigator
• •Patients with a history of ocular inflammation or macular edema
• •Patients with allergy or inability to receive intracameral antibiotic
• •Patients on systemic non-steroidal anti-inflammatory drugs (NSAID) grater than 1,200 mg/day
• •Patient with a corticosteriod implant (i.e. Ozurdex).
• •Patient with corneal pathology which pre-disposes them to unsatisfactory outcomes